Improved Revenues Required Before Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock's 27% Jump Looks Justified

Simply Wall StNov 23 20:31

Insiders At Aurinia Pharmaceuticals Sold US$2.0m In Stock, Alluding To Potential Weakness

Simply Wall StNov 22 18:44

Analysts Offer Insights on Healthcare Companies: Aurinia Pharmaceuticals (AUPH) and Siemens Healthineers AG (OtherSEMHF)

TipRanksNov 20 09:40 · Ratings

Aurinia Pharmaceuticals Celebrates New Lupus Nephritis Guidelines

TipRanksNov 19 07:42

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis

BusinesswireNov 19 06:53

Express News | Aurinia Commends 2024 Updated Acr Guidelines for Screening, Treatment, and Management of Lupus Nephritis

BreakingsNov 19 06:53